Refine by
Surgical Intervention Articles & Analysis
57 news found
Ipratropium bromide, antihistamines, and cromolyn sodium have little, if any, effect over placebo on nasal obstruction in NICR.5-7 Although most patients obtain relief of nasal obstruction with oral sympathominietics, long-term usage is cautioned in view of the associated side effects.8 It follows that one half of those with the common problem of nasal obstruction from NICR may become candidates ...
However, the results should be taken with caution since it is a technology in the research phase, in which a pilot clinical study has been carried out with a small sample of subjects (3 cases). After the intervention, the three subjects were able to stand up and remain standing; and with months of training and rehabilitation they returned to walking with the help of a harness and ...
The products of four hydrogel companies Sawhney founded with his partner Fred Khosravi (within their accelerator Incept LLC), have treated more than five million patients across the ophthalmic, surgical, interventional cardiology, and prostate cancer specialties. Sawhney founded Confluent Surgical in 1998, which, after proving out a hydrogel ...
Having a treatment that can help patients breathe easier and live a better quality of life, without surgical intervention, will be a major step forward in COPD care in ...
Prostate cancer is the most common type of cancer in men. Every year this diagnosis is made about 900 thousand times, in developed countries the disease affects up to 14% of the entire male population with oncology due to longer life expectancy. We spoke with adult prostate cancer survivors. ...
Plus, if the patient is able to perform physical therapy and it’s effective, then there may no longer be a need for surgical intervention whatsoever. The epidural injection site will vary depending on the patients’ needs. ...
” Amsel Medical’s SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures including ducts – for surgical and interventional procedures. About Amsel Medical Corporation Amsel Medical Corporation is a medical device venture ...
"The ability to rapidly and effectively control non-compressible and junctional hemorrhage non-surgically will be critical in the future operating environment," said Colonel(ret) John Dorsch who served most recently as the U.S. ...
The device remains in place for 10 days, until the body’s natural healing and tissue repair processes are complete, after which it is removed during an endoscopic procedure without the need for a second surgical intervention. This enables patients to resume their normal life without the stigma and complications associated with an ostomy procedure. ...
BySafeHeal
” Procyrion’s novel technology, Aortix, which is thinner than a #2 pencil, is the first catheter-based heart pump designed specifically to address cardiorenal syndrome in chronic heart failure patients who are failing medical therapy, but not sick enough for risky surgical interventions like heart transplants or LVADs. The unique placement of the ...
His patient-centered approach to vein care has enabled him to create and improve a number of today’s most advanced non-invasive surgical techniques. Dr. Kabnick holds patents for the development of devices used during endovenous thermal treatment. ...
” Amsel Medical’s SCureClamp™ with Interdigitation Occlusion Technology (iDOT™) is designed to easily and securely close vessels – veins, arteries, and tubular structures including ducts – for surgical and interventional procedures. About Amsel Medical Corporation Amsel Medical Corporation is a medical device venture ...
“Treatment of rectal cancer most often involves radiation and chemotherapy followed by surgical removal of the rectum. Because the risk of non-healing of the bowel anastomosis is high, and the consequences could be dire, the surgeon temporarily diverts the stool from the anastomosis by creating an ostomy. ...
BySafeHeal
Previous to this, Rob held leadership positions as the Vice President of Strategic Accounts for Surgical Specialties Corporation, and the U.S. General Manager for Nervomatrix. ...
Today, advances in glaucoma management with MIGS are presenting new opportunities for early surgical intervention in patients with mild to moderate glaucoma. Patients who receive MIGS earlier in their disease management may benefit from less reliance on adherence to prescription eye drops, slowed progression of disease, improved management of intraocular pressure ...
Retreatment rates, defined as needing BPH medication or surgical intervention, was approximately 1% per year for Aquablation, which was a 51% reduction compared to TURP. ...
Checkpoint Surgical, Inc., the leader in intraoperative nerve repair stimulation technology, today announced it has enrolled the first patient in its multi-center clinical study of the company’s breakthrough nerve regeneration technology. ...
Prior to joining NeuroSigma he completed a post-doctoral program at UCLA’s Center for Advanced Surgical and Interventional Technology (CASIT) and was a resident physician in the UCLA Department of Surgery. ...
The breakthrough findings position the Hydrus Microstent as the first glaucoma procedure to reduce vision loss compared to standard medical treatment in a large randomized clinical trial since trabeculectomy, the gold standard surgical intervention for glaucoma, first did so in the Collaborative Initial Glaucoma Treatment Study over 20 years ago. ...
Additionally, the Nalu software controlling the mIPG can be non-invasively upgraded so patients can benefit from future FDA-authorized therapy options and advancements without additional surgical interventions. The Dual 4 mIPG builds on the original Nalu mIPG technology and consists of dual connectors designed to accommodate two 4-contact stimulation leads. ...